BeStock  

Guardian Pharmacy Services GRDN

US equityMarket cap rank #2434Medical Care Facilities
$46.94 +$0.27 (+0.58%)
Market closed · Nov 22, 6:40 am ET · Last extended-hours $46.94 0.00%
Open$46.40
Prev close$46.67
Day range$46.13 – $47.48
Volume526.7K
Market cap$2.97B
P/E (TTM)40.1
Dividend yield–

Earnings

Average move on report day±6.3%last 9 reports
Closed higher5 of 956% of the time
Best reaction+13.8%
Worst reaction-10.7%

Stock move on the day after each report

-10.7%2024/Q3+4.4%2024/Q4-4.0%2025/Q1+13.8%2025/Q2+5.0%2025/Q3-0.7%2025/Q4-0.8%2026/Q1+11.0%2026/Q2+6.3%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026After Market±12.8%+6.32%Within range
2026/Q26 Aug 2026After Market±13.3%+11.05%Within range
2026/Q16 May 2026After Market±12.7%-0.85%Within range
2025/Q411 Mar 2026After Market±13.2%-0.72%Within range
2025/Q310 Nov 2025After Market–+5.04%–
2025/Q211 Aug 2025After Market–+13.78%–
2025/Q112 May 2025After Market–-3.98%–
2024/Q426 Mar 2025After Market–+4.35%–
2024/Q312 Nov 2024After Market–-10.73%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$371.07M-1.7% YoY
Operating profit$25.06M+53.3% YoY
Net profit$19.12M+99.3% YoY
Diluted EPS$0.29+93.3% YoY
Free cash flow$39.34M+71.3% YoY
Operating cash flow$43.37M

Revenue, last 8 quarters

$338.6MDec '24$329.3MMar '25$344.3MJun '25$377.4MSep '25$397.6MDec '25$336.6MMar '26$351.8MJun '26$371.1MSep '26

Net profit, last 8 quarters

$11.8MDec '24$9.3MMar '25$8.8MJun '25$9.6MSep '25$21.3MDec '25$13.5MMar '26$22.1MJun '26$19.1MSep '26

Profitability & balance sheet

Gross margin22.4%
Operating margin6.5%
Net margin5.1%
Return on equity33.2%
Return on assets17.0%
Return on invested capital28.9%
Current ratio1.65
Liabilities / assets43.1%
Cash & investments$119.66M
Total debt$27.96M
Net cash (debt)$91.69M
Free cash flow / sales6.6%

Discussion

No comments yet — be the first to weigh in on GRDN.

Sign in to join the discussion.

Scroll to Top